COMPASS THERAPEUTICS, INC. Other Income and Expense
COMPASS THERAPEUTICS, INC. (CMPX) reported Other Income and Expense of -$1.66 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-05.
Discontinued › Income Statement › Other Income
us-gaap:NonoperatingIncomeExpense · last filed 2021-03-05
- COMPASS THERAPEUTICS, INC. nonoperating income (expense) for the quarter ending 2020-12-31 was -$441.00K.
- COMPASS THERAPEUTICS, INC. nonoperating income (expense) for the quarter ending 2020-09-30 was -$189.00K.
- COMPASS THERAPEUTICS, INC. nonoperating income (expense) for the quarter ending 2020-06-30 was -$471.00K.
- COMPASS THERAPEUTICS, INC. nonoperating income (expense) for the quarter ending 2020-03-31 was -$555.00K.
- COMPASS THERAPEUTICS, INC. nonoperating income (expense) for fiscal 2020 was -$1.66M.
- COMPASS THERAPEUTICS, INC. nonoperating income (expense) for fiscal 2019 was -$601.00K.
| Period end | Nonoperating Income (Expense) 3 month | Nonoperating Income (Expense) 6 month | Nonoperating Income (Expense) 9 month | Nonoperating Income (Expense) 12 month |
|---|---|---|---|---|
| 2020-12-31 | -$441.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-05 | -$630.00K derived: sum of 2 quarters · filed 2021-03-05 | -$1.10M derived: sum of 3 quarters · filed 2021-03-05 | -$1.66M 10-K · filed 2021-03-05 |
| 2020-09-30 | -$189.00K 10-Q · filed 2020-11-09 | -$660.00K derived: sum of 2 quarters · filed 2020-11-09 | -$1.22M 10-Q · filed 2020-11-09 | -$1.42M derived: sum of 4 quarters · filed 2021-03-05 |
| 2020-06-30 | -$471.00K 10-Q · filed 2020-08-13 | -$1.03M 10-Q · filed 2020-08-13 | -$1.23M derived: sum of 3 quarters · filed 2021-03-05 | -$1.37M derived: sum of 4 quarters · filed 2021-03-05 |
| 2020-03-31 | -$555.00K derived: 10-K 12 month − 3 quarters · filed 2021-03-05 | -$755.00K derived: sum of 2 quarters · filed 2021-03-05 | -$898.00K derived: sum of 3 quarters · filed 2021-03-05 | -$1.01M derived: sum of 4 quarters · filed 2021-03-05 |
| 2019-12-31 | -$200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-05 | -$343.00K derived: sum of 2 quarters · filed 2021-03-05 | -$453.00K derived: sum of 3 quarters · filed 2021-03-05 | -$601.00K 10-K · filed 2021-03-05 |
| 2019-09-30 | -$143.00K 10-Q · filed 2020-11-09 | -$253.00K derived: sum of 2 quarters · filed 2020-11-09 | -$401.00K 10-Q · filed 2020-11-09 | |
| 2019-06-30 | -$110.00K 10-Q · filed 2020-08-13 | -$258.00K 10-Q · filed 2020-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |